Compare Impinj Inc (PI) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Impinj Inc vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Impinj Inc trades at $189.56 (market cap $5.60B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.78 (market cap $2.27B). The key difference: Impinj Inc is far larger — about 2.5× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Impinj Inc is more actively traded (9,929 versus 4,179,659). Which is the better fit depends on your goals.
| PI | SLS | |
|---|---|---|
Market Cap | $5.60B | $2.27B |
Volume | 9,929 | 4,179,659 |
Sector | Technology | Health |
52-Week High | $241.91 | $15.46 |
52-Week Low | $91.34 | $1.39 |
Typical Hold Time | 22 Days | — |
Enterprise Value | $5.73B | $2.14B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Impinj (PI) trades at $189.16, down 0.98% on the day, with strong analyst support (16 buy ratings, 0 sell) and a consensus price target of $178.83. The stock shows bullish technical momentum with recent earnings beats in Q1 and Q2 2026, though profitability remains negative with a -7.26% net income margin. Recent news highlights include upcoming Q3 earnings and CFO stock sales.
While technical indicators and analyst sentiment are positive, fundamental challenges persist with negative ROE and high valuation multiples. The company's RAIN RFID technology presents growth opportunities in logistics, but investors should weigh execution risks against the bullish consensus.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Impinj Inc
Impinj, Inc. is a leading provider of RAIN RFID (radio-frequency identification) solutions. The company's platform includes endpoints (tag chips), connectivity devices (readers and gateways), and software, enabling businesses to wirelessly identify, locate, and authenticate everyday items. Impinj's technology is crucial for applications in retail, supply chain management, healthcare, and logistics, helping businesses to automate inventory, track assets, and improve operational efficiency.
Read more on PI →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
